Apollo Capital – Curia

WA-10020

Various corporate credit and asset-backed finance-focused funds managed by affiliates of Apollo Capital Management, L.P. (**Apollo Capital or the Apollo Capital Funds**) propose to indirectly acquire the majority of the equity of UIC Parent Corporation, its subsidiary Curia Global, Inc. and/or the subsidiaries of Curia Global (together, **Curia**) (the Acquisition). Apollo Capital is a wholly-owned indirect subsidiary of Apollo Global Management, Inc. (**AGM**, together with the indirect subsidiaries of AGM managing the investment funds, **Apollo**). Apollo is a global alternative asset manager organised under the laws of the United States of America and headquartered in New York. As of 31 March 2026, Apollo had approximately US$1.03 trillion of assets under management. Examples of current investments include, inter alia, companies in education, insurance, financial services, and leisure businesses. Curia is a US-headquartered global contract research, development and manufacturing organisation. Curia has a range of solutions across the drug development spectrum, including in small molecule, generic active pharmaceutical ingredients, biologics, sterile drug product and analytical testing services.